Literature DB >> 17513902

Biological intercomparison using gut crypt survivals for proton and carbon-ion beams.

Akiko Uzawa1, Koichi Ando, Yoshiya Furusawa, Go Kagiya, Hiroshi Fuji, Masaharu Hata, Takeji Sakae, Toshiyuki Terunuma, Michael Scholz, Sylvia Ritter, Peter Peschke.   

Abstract

Charged particle therapy depends on biological information for the dose prescription. Relative biological effectiveness or RBE for this requirement could basically be provided by experimental data. As RBE values of protons and carbon ions depend on several factors such as cell/tissue type, biological endpoint, dose and fractionation schedule, a single RBE value could not deal with all different radiosensitivities. However, any biological model with accurate reproducibility is useful for comparing biological effectiveness between different facilities. We used mouse gut crypt survivals as endpoint, and compared the cell killing efficiency of proton beams at three Japanese facilities. Three Linac X-ray machines with 4 and 6 MeV were used as reference beams, and there was only a small variation (coefficient of variance < 2%) in biological effectiveness among them. The RBE values of protons relative to Linac X-rays ranged from 1.0 to 1.11 at the middle of a 6-cm SOBP (spread-out Bragg peak) and from 0.96 to 1.01 at the entrance plateau. The coefficient of variance for protons ranged between 4.0 and 5.1%. The biological comparison of carbon ions showed fairly good agreement in that the difference in biological effectiveness between NIRS/HIMAC and GSI/SIS was 1% for three positions within the 6-cm SOBP. The coefficient of variance was < 1.7, < 0.6 and < 1.6% for proximal, middle and distal SOBP, respectively. We conclude that the inter-institutional variation of biological effectiveness is smaller for carbon ions than protons, and that beam-spreading methods of carbon ions do not critically influence gut crypt survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17513902     DOI: 10.1269/jrr.48.a75

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  5 in total

1.  Development of a therapeutically important radiation induced promoter.

Authors:  Ryohei Ogawa; Akihiro Morii; Akihiko Watanabe; Zheng-Guo Cui; Go Kagiya; Shigekazu Fukuda; Kyo Kume; Takashi Hasegawa; Masanori Hatashita; Hironori Izumi; Tetsuya Ishimoto; Loreto B Feril
Journal:  Bioengineered       Date:  2012-08-28       Impact factor: 3.269

2.  Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.

Authors:  Vijay P Raturi; Hidehiro Hojo; Kenji Hotta; Hiromi Baba; Ryo Takahashi; Toshiya Rachi; Naoki Nakamura; Sadamoto Zenda; Atsushi Motegi; Hidenobu Tachibana; Takaki Ariji; Kana Motegi; Masaki Nakamura; Masayuki Okumura; Yasuhiro Hirano; Tetsuo Akimoto
Journal:  Radiat Oncol       Date:  2020-06-22       Impact factor: 3.481

3.  Radiobiological effects and proton RBE determined by wildtype zebrafish embryos.

Authors:  Emília Rita Szabó; Michael Brand; Stefan Hans; Katalin Hideghéty; Leonhard Karsch; Elisabeth Lessmann; Jörg Pawelke; Michael Schürer; Elke Beyreuther
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

4.  Relative biological effectiveness of therapeutic proton beams for HSG cells at Japanese proton therapy facilities.

Authors:  Mizuho Aoki-Nakano; Yoshiya Furusawa; Akiko Uzawa; Yoshitaka Matsumoto; Ryoichi Hirayama; Chizuru Tsuruoka; Takashi Ogino; Teiji Nishio; Kazufumi Kagawa; Masao Murakami; Go Kagiya; Kyo Kume; Masanori Hatashita; Shigekazu Fukuda; Kazutaka Yamamoto; Hiroshi Fuji; Shigeyuki Murayama; Masaharu Hata; Takeji Sakae; Hideki Matsumoto
Journal:  J Radiat Res       Date:  2014-04-03       Impact factor: 2.724

5.  Dose-Volume and Radiobiological Model-Based Comparative Evaluation of the Gastrointestinal Toxicity Risk of Photon and Proton Irradiation Plans in Localized Pancreatic Cancer Without Distant Metastasis.

Authors:  Vijay P Raturi; Taku Tochinai; Hidehiro Hojo; Toshiya Rachi; Kenji Hotta; Naoki Nakamura; Sadamoto Zenda; Atsushi Motegi; Takaki Ariji; Yasuhiro Hirano; Hiromi Baba; Hajime Ohyoshi; Masaki Nakamura; Masayuki Okumura; Yanping Bei; Tetsuo Akimoto
Journal:  Front Oncol       Date:  2020-10-23       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.